AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study
Sponsor: Medacta International SA
A NA clinical study on Arthritis and Avascular Necrosis, this trial is ongoing. The trial is conducted by Medacta International SA and has accumulated 10 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Nov 2022 — Jan 2024 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Mar 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Mar 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medacta International SA
For direct contact, visit the study record on ClinicalTrials.gov .